Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

MAP-2020-1000x250

MAP is the leading congress in precision medicine in oncology in Europe, established by key opinion leaders in the field.

By attending MAP, participants will learn how to integrate insights from tumour sample analysis into daily practice, how to seek and identify actionable mutations in patient DNA and how to provide the best possible personalised treatment.

Founded by Jean-Charles Soria, Fabrice André and Charles Swanton, the MAP Congress has established itself as a point of reference for all specialists willing to create a bright future for precision medicine in oncology, by delivering a highly specific, minimally toxic and dramatically effective treatment for each patient.

The MAP Congress is the result of a close partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, which are all committed to offer the best care to people with cancer, nationally and worldwide, through oncology education and research.

Fast Facts: MAP 2020

  • Expecting over 400 participants
  • 1 workshop
  • No parallel sessions
  • 2 Keynote lectures
  • 37 key opinion leaders
  • Excellent networking opportunities

How can I participate in MAP 2020?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congress.

For sponsorship information and a prospectus please contact:

Jon Roberts
Head of Strategic Partnerships
jon.roberts@esmo.org

We look forward to hearing from you!

Official Italian agency for AIFA procedure

AIFA rules are mandatory only for Italian Pharmaceutical Companies that will attend a congress abroad.

Any pharmaceutical company supporting supporting or participating in a congress, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorisation must be submitted within 60 days before the starting date of the even.

ESMO advises pharmaceutical companies to contact the Official Agency:

AIM Group International – AIM Education S.r.l.
Contact: Valentina Disabato/ Crisitina Ghidoli
Via G. Ripamonti, 129
20141 Milan – Italy
Tel.: +39 02 56601 1
Fax.: +39 02 70048585
E-mail: aifa@aimgroup.eu

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings